Hydrochloric Acid → N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-(2-hydroxyethyl)-4,5-(methylenedioxy)benzyl]thieno[2,3-b]pyridine-3-sulfonamide
반응식
[Cl:1][C:2]1[C:3]([CH3:42])=[N:4][O:5][C:6]=1[N:7](COCCOC)[S:8]([C:11]1[C:19]2[C:14](=[N:15][CH:16]=[CH:17][CH:18]=2)[S:13][C:12]=1[CH2:20][C:21]1[CH:26]=[C:25]2[O:27][CH2:28][O:29][C:24]2=[CH:23][C:22]=1[CH2:30][CH2:31][O:32]C(=O)C)(=[O:10])=[O:9].Cl>CO>[Cl:1][C:2]1[C:3]([CH3:42])=[N:4][O:5][C:6]=1[NH:7][S:8]([C:11]1[C:19]2[C:14](=[N:15][CH:16]=[CH:17][CH:18]=2)[S:13][C:12]=1[CH2:20][C:21]1[CH:26]=[C:25]2[O:27][CH2:28][O:29][C:24]2=[CH:23][C:22]=1[CH2:30][CH2:31][OH:32])(=[O:9])=[O:10]참가 물질
4
반응물 2
생성물 1
시약·촉매·용매 1
실험 절차
The title compound was prepared by the method of Example 4(D) using N-(4-chloro-3-methyl-5-isoxazolyl)-N-(methoxyethoxymethyl)-2-{2-[2-(acetoxy)ethyl]-4,5-(methylenedioxy)benzyl}thieno[2,3-b]pyridine-3-sulfonamide (83 mg, 0.13 mmoles), methanol (3 ml) and 4N HCl (1 ml). Recrystallization from CH2Cl2/hexanes provided 55 mg (84%) of the title compound as a white solid, m.p. 104-106° C.
후처리
- customThe title compound was prepared by the method of Example 4(D)
- customRecrystallization from CH2Cl2/hexanes
출처 및 근거
- ORD 기록
- ord-9684cb368ff441e4a5bd8a4f09a9ddf7
- 출처 데이터셋
- uspto-grants-2001_12
- 특허 번호
- US06329387B2
반응 노트
불러오는 중…